DIN 02542269 — VYEPTI 300 MG
VYEPTI is a solution of Eptinezumab marketed by LUNDBECK CANADA INC. The full Eptinezumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02542269
- Brand name
- VYEPTI
- Active ingredient
- Eptinezumab
- Strength
- 300 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- LUNDBECK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Calcitonin gene-related peptide (CGRP) inhibitor (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Eptinezumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02510839 | VYEPTI | 100 MG | SOLUTION | LUNDBECK CANADA INC | MARKETED |